How should the private and public sectors adapt to further the effort to vaccinate the U.S. population, produce sufficient supplies for countries that have thus far had only limited access to the vaccine, and develop booster vaccines to maintain immunity, particularly in the face of new variants?
Please join us for an interactive discussion with some of Columbia University’s leading experts:
Dr. Wafaa El-Sadr, MD, MPH, MPA - Professor of Epidemiology and Medicine, Director of ICAP at Columbia University, Director of Columbia World Projects and the Mathilde Krim-amfAR Professor of Global Health at the Columbia Mailman School of Public Health
Professor Bhaven Sampat - Associate Professor at the Department of Health Policy and Management at Columbia University
Dr. Magda Sobieszczyk - Harold C. Neu Professor of Infectious Diseases (in Medicine) and Chief, Division of Infectious Diseases at Columbia University Irving Medical Center
Professor Ashley Swanson (Moderator) - Assistant Professor at Columbia University's Business School
Topics for discussion will include i) new variants and the urgency of the Covid-19 vaccine campaign, ii) public and private sector investment and incentives for vaccine innovation and production, iii) global partnerships to increase vaccine capacity and improve allocation, and iv) how to maintain or improve incentives for innovation to protect against future pandemics.
The session will include open discussion and audience Q&A.